McLean, J.: The thromboplastic action of cephalin. Am. J. Physiol. , 41: 250, 1916.
2.
Howell, W.H. , AND Holt, E.: Two new factors in blood coagulation, heparin and proantithrombin. Am. J. Physiol., 47: 328, 1918.
3.
Litwins, J., Vorzimer, J.J., Sussman, L.N., Applezweig, N., AND Etess, A.D.: Sublingual administration of heparin. Proc. Soc. Exper. Biol. &Med., 77: 325, 1951.
4.
McDevitt, E. , Huebner, R.D., AND Wright, I.S.: Ineffectiveness of heparin by sublingual administration. J. A. M. A., 148: 1123, 1952 .
5.
Gelshoj, C., Gjol, N., Heintzelmann, F., AND Simonsen, V.: Treatment with heparin sublingually. Acta med. scandinav. , 287: 61, 1953.
6.
Hahn, P.F.: Abolishment of alimentary lipemia following injection of heparin. Science, 98: 19, 1943.
7.
Anfinsen, C.B. , Boyle, E., AND Brown, R.K.: The role of heparin in lipoprotein metabolism . Science, 115: 583, 1952.
8.
Korn, E.D.: Clearing factor, a heparin-activated lipoprotein lipase. J. Biol. Chem., 215: 1 and 215: 15, 1955.
9.
Graham, D.M. , Lyon, T.P., Gofman, J.W., Jones, H.B., Yankley, A., Simonton, J., AND White, S.: Blood lipids and human atherosclerosis: influence of heparin upon lipoprotein metabolism. Circulation , 4: 666, 1951.
10.
Engelberg, H. : A controlled study of the effect of intermittent heparin therapy on the course of human coronary atherosclerosis. Circulation, 13: 489, 1956.
11.
Kuo, P.T., AND Joyner, C.R.: Effect of heparin on lipemia induced angina pectoris. J. A. M. A., 163: 727, 1957.
12.
Council On Drugs: Use of heparin sodium in hyperlipemia. J. A. M. A., 166: 52, 1958.
13.
Dragstedt, L.R., Van Prohaska , J., AND Harms, H.P.: Observations on a substance in pancreas which permits survival and prevents liver changes in depancreatized dogs. Am. J. Physiol., 117: 175, 1936 .
14.
Laborit, H. , Delga, J., Baylon , H., Hugonot, R., AND Dechen, J.: La therapeutique heparinelipocaic par administration sub-linguale. Presse Méd ., 62: 79, 1954.
15.
Scardigli, G., Salvini, L., AND Aradas, A.: L'absorption de l'heparine par voie sub-linguale . Presse Méd., 63: 1140, 1955.
16.
Bono, F., AND Cortinovis, R.: Resultats cliniques et modifications physico-cliniques des lipo-proteines seriques obtenus avec l'association heparine-lipocaique dans l'atherosclerose . Minerva chir., 10: 1, 1955.
17.
Bianchani, G.: The distribution of lipoproteins in atherosclerosis and heparin by the sublingual route. Gior. clin. med., 39: 1900, 1958.
18.
Moreton, J.R. : Chylomycronemia, fat tol. erance, and atherosclerosis . J. Lab. & Clin. Med., 35: 373, 1950.
19.
Block, W.J. , Barker, N.W. AND Mann, F.D.: Effect of small doses of heparin in increasing the translucence of plasma during alimentary lipemia. Circulation , 4: 674, 1951.
20.
Rubio, F., AND Nitzberg, S.I.: Personal communication.
21.
Thomas, W.A. , AND Olwin, J.H.: Variations in protamine titration results in the blood of atherosclerotic patients. Angiology , 9: 279, 1958.
Shaftel, H.E. , AND Selman, D.: The effect of sublingual heparin on hyperlipemic serum. Angiology, 10: 131, 1959.
25.
Berkowitz, D., Likoff, W., AND Spitzer, J.J.: The effect of sublingual heparin on lipid partition and radioactive fat tolerance. Clin. Res., 7: 255, 1959.
